| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |